Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in a patient with graft-versus-host disease

被引：0

作者：

Kuhnowski F. ^{[1
]}

Terriou L. ^{[1
]}

Magro L. ^{[1
]}

Jouet J.-P. ^{[1
]}

Yakoub-Agha I. ^{[1
]}

机构：

[1] Service des Maladies du Sang, UAM Allogreffes de CSH, CHRU, Lille

来源：

Drugs | 2006年 / 66卷 / Suppl 2期

关键词：

Imatinib; Tacrolimus; Chronic Myeloid Leukaemia; Mycophenolate Mofetil; Busulfan;

D O I：

10.2165/00003495-200666002-00009

中图分类号：

学科分类号：

摘要：

[No abstract available]

引用

页码：29 / 31

页数：2

共 50 条

[1] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in a patient with graft-versus-host disease
Kuhnowski, Frederique
Terriou, Louis
Magro, Leonardo
Jouet, Jean-Pierre
Yakoub-Agha, Ibrahim
[J]. DRUGS, 2006, 66 : 29 - 31
[2] Resolution of gastrointestinal side effects in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)
Tuncer, Murat
[J]. DRUGS, 2006, 66 : 9 - 10
[3] Resolution of gastrointestinal side effects in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)
Tuncer M.
[J]. Drugs, 2006, 66 (Suppl 2) : 9 - 10
[4] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) resolves gastrointestinal disorders in a patient with severe idiopathic aplastic anaemia
Rohrlich, Pierre-Sinion
Deconinck, Eric
Cahn, Jean-Yves
Plouvier, Emmanuel
[J]. DRUGS, 2006, 66 : 33 - 35
[5] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) resolves gastrointestinal disorders in a patient with severe idiopathic aplastic anaemia
Rohrlich P.-S.
Deconinck E.
Cahn J.-Y.
Plouvier E.
[J]. Drugs, 2006, 66 (Suppl 2) : 33 - 35
[6] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in patients with gastrointestinal side effects:: Case studies
Boswell, Anita
Shehata, Magdi
[J]. DRUGS, 2006, 66 : 19 - 22
[7] Conversion from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic®) in Patients with Gastrointestinal Side Effects: Case Studies
Anita Boswell
Magdi Shehata
[J]. Drugs, 2006, 66 (Suppl 2) : 19 - 22
[8] Resolution of severe diarrhoea and return to work in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)
Lord H.
[J]. Drugs, 2006, 66 (Suppl 2) : 11 - 13
[9] Resolution of severe diarrhoea and return to work in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)
Lord, Helene
[J]. DRUGS, 2006, 66 : 11 - 13
[10] Successful conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (Myfortic®) in liver transplant patients with gastrointestinal side effects
Robaeys, G.
Cassiman, D.
Verslype, C.
Monbaliu, D.
Aerts, R.
Pirenne, J.
Nevens, F.
[J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S94 - S94

← 1 2 3 4 5 →